Sanofi’s Venglustat shows breakthrough results in rare neurological Gaucher disease
Venglustat, a glucosylceramide synthase inhibitor (GCSi), works by reducing the abnormal buildup of sugar-and-fat molecules in cells and organs
Venglustat, a glucosylceramide synthase inhibitor (GCSi), works by reducing the abnormal buildup of sugar-and-fat molecules in cells and organs
The integration unifies brand and field strategy, drives executional alignment, and delivers immediate impact measurement
The move strengthens GBL’s clinical-stage presence in the United States
Acromegaly, a rare chronic endocrine disorder caused by excess growth hormone, is seeing promising advances in treatment development
The issue comprises a fresh issue of Rs. 95 crore and targeting a total raise of around Rs. 895 crore
The expanded mbDNA portfolio delivers enhanced stability, reduced immunogenicity, and broad compatibility with gene insertion and expression technologies
Dr. Jindal reflects on bridging accessibility gaps between urban and rural regions, the ethical and emotional aspects of family building, and how initiatives like adoption facilitation centers align with his lifelong mission to help couples realize the dream of parenthood
PeptiGlow features premium-grade hydrolyzed collagen peptides that support skin elasticity and hydration
Zydus Pinkathon will be led by women to raise awareness on breast cancer and women's health
Subscribe To Our Newsletter & Stay Updated